Weight-Loss drug could help break meth addiction
NCT ID NCT07204249
Summary
This study is testing whether semaglutide (sold as Wegovy for weight loss) can help people reduce or stop using methamphetamine. The trial will involve 162 adults with moderate to severe methamphetamine addiction who want to quit or cut back. Researchers will compare results between participants receiving the actual medication and those receiving a placebo to see if it helps control addiction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE-DEPENDENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.